General Information
Revision date
2020-10-10
Product name
Mometasone Dry Powder Inhaler Formulation
CAS No.
83919-23-7
1.2.1 Relevant identified uses
Pharmaceutical
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360Df, H373, H410
Hazard statements
Code
Statements
H360Df
May damage the unborn child; Suspected of damaging fertility
Section 2
CLP CLASSIFICATION
Reproductive toxicity, Category 1B H360Df: May damage the unborn child. Suspected of damaging fertility. Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure. Long-term (chronic) aquatic hazard, Cat- H410: Very toxic to aquatic life with long lasting egory 1 effects.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Danger
Hazard statements
H360Df May damage the unborn child. Suspected of damaging fertility. H373 May cause damage to organs through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe dust. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage.
Hazardous Ingredients
Mometasone
2.3 Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means.
